Ruchi Jhonsa
WRITTEN BY Ruchi Jhonsa
Pfizer Strengthens Immuno-Oncology Portfolio with $200 Million Investment in Chinese Startup
2020-10-03
Investors Back Seattle-Based Startup’s Novel Immuno-Oncology Program Targeting Solid Tumors
2020-09-26
Vaccinex’s Drug Flounders Huntington’s Trial, but Shows Promise against Another Neurodegenerative Disease
2020-09-24